The FDA reviewed the rule under the Order and concluded that the affect of the final rule would not constitute a taking of private property.
A taking of private property would not be constituted by the affect of the final rule, as FDA concluded after reviewing the rule under the Order.
The final rule would constitute taking of a private property, due to its' affect.